(420) NEO6860, a novel modality selective TRPV1 antagonist: results from a phase I, double-blind, placebo-controlled study in healthy subjects

Autor: Chiche, D., Brown, W., Walker, P.
Zdroj: In Journal of Pain April 2016 17(4) Supplement:S79-S79
Databáze: ScienceDirect